Lifespan Vision Ventures Invests in TECregen’s Seed Financing
Norwalk, CT – January 8, 2026 - Lifespan Vision Ventures, an investment firm focused on therapeutics that improve human healthspan, today announced an investment in TECregen’s CHF 10 million seed financing round. Lifespan Vision Ventures joins lead investor Boehringer Ingelheim Venture Fund (BIVF), along with Carma Fund, EOS BioInnovation, High-Tech Gründerfonds (HTGF), the JFG Life Sciences Foundation of the University of Basel, and Zurich Cantonal Bank. TECregen is developi
Lifespan Vision Ventures Visits San Francisco During JPM Healthcare Week
Norwalk, CT – January 5, 2026 - Lifespan Vision Ventures will be in San Francisco from January 12-15, connecting with the healthcare and life sciences community during JPM Healthcare Week. Throughout the week, our team will be meeting with founders, investors, operators, and partners. We’ll be engaging with groups advancing healthspan through new therapeutics and platform technologies at events and conversations across the city. JPM Healthcare Week is an energizing moment to
Lifespan Vision Ventures Invests in Paulex Bio
Norwalk, CT – November 24, 2025 - Lifespan Vision Ventures, an investment firm focused on therapeutics that improve human healthspan, today announced an investment in Paulex Bio as part of MDB Capital’s $16.8 million private placement, supporting the company’s development of a first-in-class oral therapy aimed at restoring the body’s ability to produce its own insulin. Paulex Bio is pioneering an oral regenerative medicine designed to help the pancreas rebuild insulin-produci
Lifespan-Backed Algen Biotechnologies Partners with AstraZeneca to Advance AI Drug Discovery
Norwalk, CT - October 09, 2025 – Lifespan Vision Ventures congratulates its portfolio company, Algen Biotechnologies, on the announcement...